Diagnostic value of vaginal discharge, wet mount and vaginal pH - An update on the basics of gynecologic infectiology

Geburtshilfe und Frauenheilkunde

Volumn 75, Issue 4, 2015, Pages 355-366

  Frobenius, Wolfgang ^a   Bogdan, C ^a  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

Author keywords

bacterial vaginosis; pelvic inflammatory disease; trichomoniasis; vaginal pH; vulvovaginal candidiasis

Indexed keywords

ANTIFUNGAL AGENT; CLINDAMYCIN; IMIDAZOLE DERIVATIVE; METRONIDAZOLE; TINIDAZOLE; TRIAZOLE DERIVATIVE;

AEROBIC VAGINITIS; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL VAGINOSIS; CANDIDIASIS; CHRONIC RECURRENT VULVOVAGINAL CANDIDIASIS; CLINICAL EXAMINATION; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; GYNECOLOGIC INFECTION; HUMAN; LAPAROSCOPY; MEDICAL HISTORY; MICROBIOLOGICAL EXAMINATION; PALPATION; PATHOGENESIS; PELVIC INFLAMMATORY DISEASE; PHYSICAL DISEASE BY BODY FUNCTION; RECURRENT DISEASE; TRANSVAGINAL ECHOGRAPHY; TRICHOMONIASIS; VAGINA CANDIDIASIS; VAGINA DISCHARGE; VAGINA FLORA; VAGINA PH; VAGINITIS;

EID: 84930201502     PISSN: 00165751     EISSN: 14388804     Source Type: Journal    
DOI: 10.1055/s-0035-1545909     Document Type: Article

References (40)

1. Mendling W. Gynäkologische Infektionen. Teil 1. Gynäkologe: 2012; 45 959 975
2. Landers D. V., Wiesenfeld H. C., Heine R. P. et al. Predictive value of the clinical diagnosis of lower genital tract infection in women. Am J Obstet Gynecol: 2004; 190 1004
3. Mendling W., Mylonas I., Neumann G. et al. Mikroskopische Infektionsdiagnostik in der Weiterbildung. Stellungnahme der Arbeitsgemeinschaft für Infektionen und Infektionsimmunologie (AGII)/189.Stellungnahme der DGGG. Frauenarzt: 2014; 55 663 665
4. Mashburn J. Vaginal infections update. J Midwifery Womens Health: 2012; 57 629 634
5. Sobel J. D. Vulvovaginitis in healthy women. Compr Ther: 1999; 25 335 346
6. Podbielski A., Herrmann M., Kniehl E. et al., Hrsg. Mikrobiologisch-infektiologische Qualitätsstandards (MiQ) 10. Genitalinfektionen Teil I. Infektionen des weiblichen und des männlichen Genitaltraktes. 2. Aufl. München Urban & Fischer: 2011
7. Podbielski A., Mauch H., Kniehl E. et al., Hrsg. Mikrobiologisch-infektiologische Qualitätsstandards (MiQ) 11a. Genitalinfektionen Teil II. Infektionserreger: Bakterien. 2. Aufl. München Urban & Fischer: 2011
8. Lamont R. F., Sobel J. D., Akins R. A. et al. The vaginal microbiome: new information about genital tract flora using molecular based techniques. BJOG: 2011; 118 533 549
9. Witkin S. S., Linhares I., Giraldo P. et al. An altered immunity hypothesis for the development of symptomatic bacterial vaginosis. Clin Infec Diseases: 2007; 44 554 557
10. Hyman R. W., Fukushima M., Diamond L. et al. Microbes on the human vaginal epithelium. Proc Natl Acad Sci U S A: 2005; 102 7952 7957
11. Senok A. C., Verstraelen H., Temmerman M. et al. Probiotics for the treatment of bacterial vaginosis. Cochrane Database Syst Rev: 2009; 4 CD006289
12. Arbeitsgemeinschaft für Infektiologie und Infektionsimmunologie (AGII) der DGGG Expertenkommission "Vaginale Infektionen" der AIG. Praktisches Vorgehen bei bakterieller Vaginose, Vulvovaginalkandidose und Trichomoniasis. Frauenarzt: 2013; 54 828 837
13. Romosan G., Valentin L. The sensitivity and specificity of transvaginal ultrasound with regard to acute pelvic inflammatory disease: a review of the literature. Arch Gynecol Obstet: 2014; 289 705 714
14. Petersen E. E. Infektionen in Gynäkologie und Geburtshilfe. Lehrbuch und Atlas. 5., neu bearbeitete und erweiterte Aufl. Stuttgart Thieme: 2011
15. Neumann G., Schäfer A., Mendling W. Phasenkontrast-Mikroskopie in der Frauenarztpraxis. Berlin, Heidelberg Springer: 2014
16. CDC Pelvic inflammatory disease. Online: http://www.cdc.gov/std/treatment/2010/pid.htm last access: 31.07.2014
17. Mendling W. Gynäkologische Infektionen. Teil 2: Zervizitis, Salpingitis und Herpes genitalis. Gynäkologe: 2013; 46 117 128
18. Ross J., Judlin P. European Guideline for the management of pelvic inflammatory disease. June: 2012; http://www.iusti.org/regions/europe/pdf/2012/PID-Treatment-Guidelines-Europe2012v5.pdf;, proposed date for review: June 2015. Online: http://www.iusti.org/regions/europe/pdf/2012/PID-Treatment-Guidelines-Europe2012v5.pdf last access: 31.07.2014
19. Mendling W. Hrsg. S1-Leitlinie AWMF-Register-Nr.015/028. Bakterielle Vaginose (BV) in Gynäkologie und Geburtshilfe. Gültig bis 31.08.2016. Online: http://www.awmf.org/leitlinien/detail/ll/015-028.html
20. Soper D. E. Bacterial vaginosis and postoperative infections. Am J Obstet Gynecol: 1993; 169 467 469
21. U.S. Preventive Services Task Force Screening for bacterial vaginosis in pregnancy to prevent preterm delivery: recommendation statement. Ann Intern Med: 2008; 148 214 219
22. Amsel R., Trotten P. A., Spiegel C. A. et al. Nonspecific vaginitis. Diagnostic criteria and microbial and epidemiologic associations. Am J Med: 1983; 74 14 22
23. Greene J. F. 3rd, Kuehl T. J., Allen S. R. The papanicolaou smear: inadequate screening test for bacterial vaginosis during pregnancy. Am J Obstet Gynecol: 2000; 182 1048
24. Klebanoff M. A., Hauth J. C., MacPherson C. A. et al. Time course of the regression of asymptomatic bacterial vaginosis in pregnancy with and without treatment. Am J Obstet Gynecol: 2004; 190 363 370
25. Burtin P., Taddio A., Ariburnu O. et al. Safety of metronidazole in pregnancy: a meta-analysis. Am J Obstet Gynecol: 1995; 172 525 529
26. Bradshaw C. S., Vodstrcil L. A., Hocking J. S. et al. Recurrence of bacterial vaginosis is significantly associated with posttreatment sexual activities and hormonal contraceptive use. Clin Infect Dis: 2013; 56 777
27. Centers for Disease Control and Prevention Bacterial vaginosis. Treatment. Online: http://www.cdc.gov/std/treatment/2010/vaginal-discharge.htm last access: 31.07.2014
28. Bradshaw C. S., Morton A. N., Hocking J. et al. High recurrence rates of bacterial vaginosis over the course of 12 months after oral metronidazole therapy and factors associated with recurrence. J Infect Dis: 2006; 193 1478
29. Swidsinski A., Mendling W., Loening-Baucke V. et al. An adherent Gardnerella vaginalis biofilm persists on the vaginal epithelium after standard therapy with oral metronidazole. Am J Obstet Gynecol: 2008; 198 97.e1 97.e6
30. Mendling W. Vaginose, Vaginitis, Zervizitis und Salpingitis. 2., erweiterte und vollständig neu bearbeitete Aufl. Heidelberg Springer: 2006
31. Mendling W. Hrsg. S-2K Leitlinie AWMF-Register-Nr.015/072.Vulvovaginalkandidose. Gültig bis 31.12.2016. Online: http://www.awmf.org/leitlinien/detail/ll/015-072.html
32. Mølgaard-Nielsen D., Pasternak B., Hviid A. Use of oral fluconazole during pregnancy and the risk of birth defects. NEJM: 2013; 369 830 839
33. Schaefer C., Spielmann H., Vetter K. et al., Hrsg. Arzneimittel in Schwangerschaft und Stillzeit. 8. Aufl. München Urban & Fischer: 2012
34. Patel D. A., Gillespie B., Sobel J. D. et al. Risk factors for recurrent vulvovaginal candidiasis in women receiving maintenance antifungal therapy: results of a prospective cohort study. Am J Obstet Gynecol: 2004; 190 644
35. Sobel J. D., Chaim W., Nagappan V. et al. Treatment of vaginitis caused by Candida glabrata: use of topical boric acid and flucytosine. Am J Obstet Gynecol: 2003; 189 1297
36. Donders G., Bellen G., Byttebier G. et al. Individualized decreasing-dose maintenance fluconazole regimen for recurrent vulvovaginal candidiasis (ReCiDiF trial). Am J Obstet Gynecol: 2008; 199 613.e1 613.e9
37. CDC Trichomoniasis. Treatment. Online: http://www.cdc.gov/std/treatment/2010/vaginal-discharge.htm last access: 31.07.2014
38. Helms D. J., Mosure D. J., Secor W. E. et al. Management of trichomonas vaginalis in women with suspected metronidazole hypersensitivity. Am J Obstet Gynecol: 2008; 198 370.e1
39. Michigan Regional Laboratory Wet Mount Proficiency Program. Online: http://www.michigan.gov/mdch/0,4612,7-132-2945-5103-7168-74548?,00.html last access: 31.07.2014
40. Bevan C. D., Ridgway G. L., Rothermel C. D. Efficacy and safety of azithromycin as monotherapy or combined with metronidazole compared with two standard multidrug regimens for the treatment of acute pelvic inflammatory disease. J Int Med Res: 2003; 31 45 54